1. High ten‐year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R‐FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study. (24th March 2017) Authors: Nastoupil, Loretta J.; McLaughlin, Peter; Feng, Lei; Neelapu, Sattva S.; Samaniego, Felipe; Hagemeister, Fredrick B.; Ayala, Ana; Romaguera, Jorge E.; Goy, Andre H.; Neal, Eleanor; Wang, Michael; Fayad, Luis; Fanale, Michelle A.; Oki, Yasuhiro; Westin, Jason R.; Rodriguez, Maria A.; Cabanillas, F... Journal: British journal of haematology Issue: Volume 177:Number 2(2017) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T‐cell lymphoma. (10th August 2015) Authors: Chihara, Dai; Pro, Barbara; Loghavi, Sanam; Miranda, Roberto N.; Medeiros, L. Jeffrey; Fanale, Michelle A.; Hagemeister, Fredrick B.; Fayad, Luis E.; Romaguera, Jorge E.; Samaniego, Felipe; Neelapu, Sattva S.; Younes, Anas; Fowler, Nathan H.; Rodriguez, M. Alma; Wang, Michael; Kwak, Larry W.; McL... Journal: British journal of haematology Issue: Volume 171:Number 4(2015:Nov.) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma. (28th February 2019) Authors: Khashab, Tamer; Hagemeister, Fredrick; Romaguera, Jorge E.; Fanale, Michelle A.; Pro, Barbara; McLaughlin, Peter; Rodriguez, M. Alma; Neelapu, Sattva S.; Fayad, Luis; Younes, Anas; Feng, Lei; Vega, Francisco; Kwak, Larry W.; Samaniego, Felipe Journal: British journal of haematology Issue: Volume 185:Number 4(2019) Page Start: 670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high‐risk follicular lymphoma due to severe haematological and infectious toxicity. (18th December 2015) Authors: Cheah, Chan Y.; Nastoupil, Loretta J.; McLaughlin, Peter; Fanale, Michelle A.; Neelapu, Sattva S.; Fayad, Luis E.; Hagemeister, Frederick B.; Fowler, Nathan H. Journal: British journal of haematology Issue: Volume 175:Number 3(2016) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Stage I-II follicular lymphoma: an endangered species?. Issue 8 (3rd August 2015) Authors: McLaughlin, Peter; Seymour, John F. Journal: Leukemia & lymphoma Issue: Volume 56:Issue 8(2015:Aug.) Page Start: 2229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. „Ordnung und Organisation". Interview zur Historiographie der Biologie mit Hans‐Jörg Rheinberger und Peter McLaughlin. Issue 3 (1st September 2021) Authors: Grote, Mathias; te Heesen, Anke; McLaughlin, Peter; Rheinberger, Hans‐Jörg Journal: Berichte zur Wissenschaftsgeschichte Issue: Volume 44:Issue 3(2021) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma. Issue 1 (2nd January 2021) Authors: Samaniego, Felipe; McLaughlin, Peter; Neelapu, Sattva S.; Feng, Lei; Fanale, Michelle; Nastoupil, Loretta; Rodriguez, Maria Alma; Pro, Barbara; Taylor, Erin; Hagemeister, Fredrick B.; Fowler, Nathan Journal: Leukemia & lymphoma Issue: Volume 62:Issue 1(2021) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma. Issue 1 (2nd January 2021) Authors: Samaniego, Felipe; McLaughlin, Peter; Neelapu, Sattva S.; Feng, Lei; Fanale, Michelle; Nastoupil, Loretta; Rodriguez, Maria Alma; Pro, Barbara; Taylor, Erin; Hagemeister, Fredrick B.; Fowler, Nathan Journal: Leukemia & lymphoma Issue: Volume 62:Issue 1(2021) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rituximab plus hyper‐CVAD alternating with MTX/Ara‐C in patients with newly diagnosed mantle cell lymphoma: 15‐year follow‐up of a phase II study from the MD Anderson Cancer Center. (9th December 2015) Authors: Chihara, Dai; Cheah, Chan Y.; Westin, Jason R.; Fayad, Luis E.; Rodriguez, Maria A.; Hagemeister, Fredrick B.; Pro, Barbara; McLaughlin, Peter; Younes, Anas; Samaniego, Felipe; Goy, Andre; Cabanillas, Fernando; Kantarjian, Hagop; Kwak, Larry W.; Wang, Michael L.; Romaguera, Jorge E. Journal: British journal of haematology Issue: Volume 172:Number 1(2016) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2‐microglobulin level in patients with diffuse large b‐cell lymphoma: a new prognostic model. (22nd July 2016) Authors: Chen, Yiming; Neelapu, Sattva; Feng, Lei; Bi, Weiqi; Yang, Tian‐Hui; Wang, Michael; Fanale, Michelle A.; Westin, Jason R.; Hagemeister, Fredrick B.; Fayad, Luis E.; Romaguera, Jorge E.; Samaniego, Felipe; Turturro, Francesco; Fowler, Nathan H.; McLaughlin, Peter; Cabanillas, Fernando; Oki, Yasuhi... Journal: British journal of haematology Issue: Volume 175:Number 2(2016) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗